RAPAMYCIN Side Effects

6231425-X | Deep Vein Thrombosis, Pericardial Effusion
on Jun 12, 2009 Female patient from UNITED STATES , weighting 162.0 lb, was diagnosed with endometrial cancer metastatic and was treated with Rapamycin (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), pericardial effusion. Rapamycin dosage: 60 Mg Weekly Po. Patient was hospitalized.

5964860-5 | Anaemia, Dehydration, Hyponatraemia, Hypovolaemia, Renal Failure Acute
Patient was taking Rapamycin (View Usage). Patient had the following side effects: anaemia, dehydration, hyponatraemia, hypovolaemia, renal failure acute on Nov 24, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 191.8 lb, was diagnosed with colon cancer metastatic and. Rapamycin dosage: 16mg Q Week Po. During the same period patient was treated with KETOCONAZOLE (200 Mg Bid X 1; Qd X 3 Po) (View Ketoconazole Review and Ketoconazole Label ). Patient was hospitalized.

5958147-4 | Ascites, Bradycardia, Dehydration, Hydronephrosis, Pleural Effusion, Small Intestinal Obstruction
Adverse event was reported on Nov 17, 2008 by a Male patient taking Rapamycin (View Usage) (Dosage: 16mg Q Week Po) was diagnosed with colorectal cancer metastatic and. Location: UNITED STATES , weighting 191.8 lb, After Rapamycin was administered, patient had the following side effects: ascites, bradycardia, dehydration, hydronephrosis, pleural effusion, small intestinal obstruction. During the same period patient was treated with KETOCONAZOLE (200 Mg Bid X 1; Qd X 3 Po) (View Ketoconazole Review and Ketoconazole Label ).

5958143-7 | Bronchitis, Candidiasis, Herpes Simplex, Hypophagia, Mouth Ulceration, Viral Pharyngitis
on Nov 17, 2008 Male patient from UNITED STATES , weighting 154.1 lb, was diagnosed with colon cancer metastatic and was treated with Rapamycin (View Usage). Patient experienced the following unwanted or unexpected effects: bronchitis (What is bronchitis?), candidiasis, herpes simplex (What is herpes simplex?), hypophagia, mouth ulceration, viral pharyngitis. Rapamycin dosage: 35 Mg Q Week Po. During the same period patient was treated with GRAPEFRUIT JUICE (8 Oz Daily Po) (View Grapefruit Juice Review and Grapefruit Juice Label ). Patient was hospitalized.


5941275-7 | Abdominal Pain, Intra-abdominal Haematoma
on Nov 03, 2008 Female patient from UNITED STATES , weighting 179.2 lb, was diagnosed with colon cancer and was treated with Rapamycin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), intra-abdominal haematoma. Rapamycin dosage: 35mg Weekly Po. During the same period patient was treated with GRAPEFRUIT JUICE (8 Oz Daily Po) (View Grapefruit Juice Review and Grapefruit Juice Label ). Patient was hospitalized.

5920874-2 | Bradycardia, Dehydration, Stent Related Infection
Patient was taking Rapamycin (View Usage). After Rapamycin was administered, patient had the following side effects: bradycardia, dehydration, stent related infection on Oct 15, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 191.8 lb, was diagnosed with colorectal cancer metastatic and. Rapamycin dosage: 16mg Q Week Po. During the same period patient was treated with KETOCONAZOLE (200mg Bid Xl, Qd X3 Po) (View Ketoconazole Review and Ketoconazole Label ). Patient was hospitalized.

5919118-7 | Orthostatic Hypotension, Oxygen Saturation Decreased, Pericardial Effusion, Tachycardia
Adverse event was reported on Oct 14, 2008 by a Male patient taking Rapamycin (View Usage) (Dosage: 35mg Weekly Po) was diagnosed with mesothelioma (What is mesothelioma?) and. Location: UNITED STATES , weighting 175.9 lb, Patient experienced the following unwanted or unexpected effects: orthostatic hypotension, oxygen saturation decreased, pericardial effusion, tachycardia. During the same period patient was treated with GRAPEFRUIT JUICE (8 Oz Daily Po) (View Grapefruit Juice Review and Grapefruit Juice Label ). Patient was hospitalized.

5848465-2 | Cough, Dyspnoea, Oxygen Saturation Decreased
on Aug 15, 2008 Male patient from UNITED STATES , weighting 227.7 lb, was diagnosed with rectal cancer metastatic and was treated with Rapamycin (View Usage). Patient had the following side effects: cough, dyspnoea, oxygen saturation decreased. Rapamycin dosage: 16mg Once A Week Po. During the same period patient was treated with KETOCONAZOLE (200mg Once A Day Po) (View Ketoconazole Review and Ketoconazole Label ). Patient was hospitalized.

5816519-2 | Oxygen Saturation Decreased, Pneumonia, Urinary Tract Infection
on Jul 17, 2008 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Rapamycin (View Usage). After Rapamycin was administered, patient had the following side effects: oxygen saturation decreased, pneumonia (What is pneumonia?), urinary tract infection (What is urinary tract infection?). Rapamycin dosage: 16 Mg Q Week Po. During the same period patient was treated with KETOCONAZOLE (200 Mg Bid Po) (View Ketoconazole Review and Ketoconazole Label ). Patient was hospitalized.

5757996-5 | Jaundice, Oedema, Pleural Effusion
Patient was taking Rapamycin (View Usage). Patient experienced the following unwanted or unexpected effects: jaundice (What is jaundice?), oedema, pleural effusion on Jun 02, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 245.6 lb, was diagnosed with gallbladder cancer metastatic and. Rapamycin dosage: 45mg Twice Weekly Po. Patient was hospitalized.

5697824-X | Cough, Disease Progression, Dyspnoea, Musculoskeletal Chest Pain
Adverse event was reported on Apr 04, 2008 by a Male patient taking Rapamycin (View Usage) (Dosage: 1 Mg X30 Days Po) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , 56 years of age, weighting 139.6 lb, Patient had the following side effects: cough, disease progression, dyspnoea, musculoskeletal chest pain. During the same period patient was treated with RATG (6 Mg/kg X4 Days Iv Drip) (View Ratg Review and Ratg Label ). Patient was hospitalized.

5638841-5 | Small Intestinal Obstruction
on Feb 21, 2008 Male patient from UNITED STATES , weighting 174.8 lb, was treated with Rapamycin (View Usage). After Rapamycin was administered, patient had the following side effects: small intestinal obstruction. Rapamycin dosage: . Patient was hospitalized.

5489579-9 | Disease Progression
on Oct 16, 2007 Male patient from UNITED STATES , weighting 156.3 lb, was treated with Rapamycin (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression. Rapamycin dosage: .

5357397-8 | Failure To Thrive, Hypotension, International Normalised Ratio Increased
Patient was taking Rapamycin (View Usage). Patient had the following side effects: failure to thrive, hypotension, international normalised ratio increased on Jun 12, 2007 from UNITED STATES Additional patient health information: Male patient , 57 years of age, weighting 193.3 lb, was diagnosed with pancreatic carcinoma metastatic and. Rapamycin dosage: 5 Mg Daily Po. Patient was hospitalized.

5341863-5 | Splenic Infarction
Adverse event was reported on May 29, 2007 by a Male patient taking Rapamycin (View Usage) (Dosage: ) . Location: UNITED STATES , 24 years of age, After Rapamycin was administered, patient had the following side effects: splenic infarction.

5203785-X | Colitis
on Jan 09, 2007 Female patient from UNITED STATES , 43 years of age, was treated with Rapamycin (View Usage). Patient experienced the following unwanted or unexpected effects: colitis. Rapamycin dosage: 3mg Qd. During the same period patient was treated with PREDNISONE TAB (10mg Qd) (View Prednisone Tab Review and Prednisone Tab Label ), IMURAN (75mg Qd) (View Imuran Review and Imuran Label ). Patient was hospitalized.

5060749-7 | Ascites, Hepatic Neoplasm Malignant, Malignant Neoplasm Progression, Pain
on Jul 21, 2006 Male patient from UNITED STATES , weighting 222.7 lb, was treated with Rapamycin (View Usage). Patient had the following side effects: ascites, hepatic neoplasm malignant, malignant neoplasm progression, pain (What is pain?). Rapamycin dosage: . Patient was hospitalized.

5032402-7 | Hypotension, Hypoxia, Pneumonia
Patient was taking Rapamycin (View Usage). After Rapamycin was administered, patient had the following side effects: hypotension, hypoxia, pneumonia (What is pneumonia?) on Jun 21, 2006 from UNITED STATES Additional patient health information: Female patient , weighting 134.5 lb, was diagnosed with metastasis, neuroendocrine tumour and. Rapamycin dosage: 20 Mg Weekly Po. Patient was hospitalized.

5025779-X | Hypotension, Hypoxia
Adverse event was reported on Jun 09, 2006 by a Female patient taking Rapamycin (View Usage) (Dosage: 20 Mg Weekly Po) was diagnosed with metastasis, neuroendocrine tumour and. Location: UNITED STATES , weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: hypotension, hypoxia. Patient was hospitalized.

5020946-3 | Dehydration, Disease Progression, Hydronephrosis, Nausea, Renal Failure Acute
on Jun 07, 2006 Female patient from UNITED STATES , weighting 119.0 lb, was diagnosed with ovarian cancer metastatic and was treated with Rapamycin (View Usage). Patient had the following side effects: dehydration, disease progression, hydronephrosis, nausea (What is nausea?), renal failure acute. Rapamycin dosage: 5 Mg Weekly Po. During the same period patient was treated with KETOCONAZOLE (200 Mg Bid X1, Qd X3 Po) (View Ketoconazole Review and Ketoconazole Label ). Patient was hospitalized.

5020540-4 | Dehydration, Disease Progression, Hydronephrosis, Renal Failure Acute
on Jun 07, 2006 Female patient from UNITED STATES , weighting 119.0 lb, was diagnosed with ovarian cancer metastatic and was treated with Rapamycin (View Usage). After Rapamycin was administered, patient had the following side effects: dehydration, disease progression, hydronephrosis, renal failure acute. Rapamycin dosage: 5 Mg Weekly Po. During the same period patient was treated with KETOCONAZOLE (200 Mg Bid X1, Qd X3 Po) (View Ketoconazole Review and Ketoconazole Label ). Patient was hospitalized.

5020530-1 | Dehydration, Disease Progression, Hydronephrosis, Nausea, Renal Failure Acute
Patient was taking Rapamycin (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, disease progression, hydronephrosis, nausea (What is nausea?), renal failure acute on Jun 07, 2006 from UNITED STATES Additional patient health information: Female patient , weighting 119.0 lb, was diagnosed with ovarian cancer metastatic and. Rapamycin dosage: 5 Mg Weekly Po. During the same period patient was treated with KETOCONAZOLE (200 Mg Bid X1, Qd X3 Po) (View Ketoconazole Review and Ketoconazole Label ). Patient was hospitalized.

5002206-X | Sinus Arrest
Adverse event was reported on May 11, 2006 by a Male patient taking Rapamycin (View Usage) (Dosage: 20 Mg Weekly Po) was diagnosed with colon cancer metastatic and. Location: UNITED STATES , weighting 213.8 lb, Patient had the following side effects: sinus arrest. Patient was hospitalized.

4965888-4 | Colitis, Dehydration, Enteritis, Failure To Thrive, Gastrointestinal Haemorrhage, Hyperglycaemia
on Apr 06, 2006 Male patient from UNITED STATES , weighting 114.6 lb, was treated with Rapamycin (View Usage). After Rapamycin was administered, patient had the following side effects: colitis, dehydration, enteritis, failure to thrive, gastrointestinal haemorrhage, hyperglycaemia. Rapamycin dosage: 5 Mg Po Daily 28 Days. During the same period patient was treated with PROTONIX (View Protonix Review and Protonix Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), AVANDIA (View Avandia Review and Avandia Label ), CLONOPIN (View Clonopin Review and Clonopin Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ). Patient was hospitalized.

4965822-7 | Ascites, Bile Duct Obstruction, Blood Bilirubin Increased
on Apr 05, 2006 Male patient from UNITED STATES , 52 years of age, weighting 183.0 lb, was treated with Rapamycin (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, bile duct obstruction, blood bilirubin increased. Rapamycin dosage: . Patient was hospitalized.

4965820-3 | Anaemia, Asthenia, Cough, Dehydration, Dyspnoea, Hypotension, Pneumonia, Pyrexia, Renal Failure
Patient was taking Rapamycin (View Usage). Patient had the following side effects: anaemia, asthenia, cough, dehydration, dyspnoea, hypotension, pneumonia (What is pneumonia?), pyrexia, renal failure on Apr 05, 2006 from UNITED STATES Additional patient health information: Male patient , weighting 154.3 lb, . Rapamycin dosage: 5mg Po Daily 28 Days. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BOLUS (View Bolus Review and Bolus Label ), KITRO (View Kitro Review and Kitro Label ), DEMEROL (View Demerol Review and Demerol Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ). Patient was hospitalized.

4911786-1 | Pulmonary Embolism
Adverse event was reported on Feb 13, 2006 by a Male patient taking Rapamycin (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 160.9 lb, After Rapamycin was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with LEXAPRO (View Lexapro Review and Lexapro Label ), LASIX (View Lasix Review and Lasix Label ), PERCOCET (View Percocet Review and Percocet Label ), TOPROL (View Toprol Review and Toprol Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), FLEETSENEMA (View Fleetsenema Review and Fleetsenema Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), DULCOLUX (View Dulcolux Review and Dulcolux Label ). Patient was hospitalized.

4882045-0 | Asthenia, Cough, Dehydration, Dyspnoea, Hypotension, Pyrexia, Troponin Increased, Vomiting, Wheezing
on Jan 13, 2006 Male patient from UNITED STATES , weighting 154.3 lb, was treated with Rapamycin (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, cough, dehydration, dyspnoea, hypotension, pyrexia, troponin increased, vomiting, wheezing. Rapamycin dosage: 5 Mg Po Daily 28 Days. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), KITRO (View Kitro Review and Kitro Label ), DEMEROL (View Demerol Review and Demerol Label ), CEFRIAXONE (View Cefriaxone Review and Cefriaxone Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ). Patient was hospitalized.

4715661-7 | Dehydration, Disease Progression, Nausea
on Jul 15, 2005 Male patient from UNITED STATES , weighting 169.8 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Rapamycin (View Usage). Patient had the following side effects: dehydration, disease progression, nausea (What is nausea?). Rapamycin dosage: 2mg Q Week Oral. During the same period patient was treated with KETOCONAZOLE (200 Mg Bid X 1 Qd X3 Oral) (View Ketoconazole Review and Ketoconazole Label ), LOVENOX (View Lovenox Review and Lovenox Label ), PANCREASE (View Pancrease Review and Pancrease Label ), NORVASC (View Norvasc Review and Norvasc Label ), ALTACE (View Altace Review and Altace Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ), COLACE (View Colace Review and Colace Label ).

4704972-7 | Dehydration, Disease Progression, Nausea
Patient was taking Rapamycin (View Usage). After Rapamycin was administered, patient had the following side effects: dehydration, disease progression, nausea (What is nausea?) on Jun 24, 2005 from Additional patient health information: Male patient , weighting 169.8 lb, was diagnosed with pancreatic carcinoma metastatic and. Rapamycin dosage: 2 Mg Po Q Week. During the same period patient was treated with KETOCONAZOLE (200 Mg Po Bid X1 , Qd X3) (View Ketoconazole Review and Ketoconazole Label ), LOVENOX (View Lovenox Review and Lovenox Label ), PANCREASE (View Pancrease Review and Pancrease Label ), NORVASC (View Norvasc Review and Norvasc Label ), ALTACE (View Altace Review and Altace Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ).

4700095-1 | Disease Progression, Pericardial Effusion, Pleural Effusion
Adverse event was reported on Jan 23, 2005 by a Male patient taking Rapamycin (View Usage) (Dosage: 1 Mg Po Q Week) was diagnosed with oesophageal cancer metastatic and. Location: , weighting 187.4 lb, Patient experienced the following unwanted or unexpected effects: disease progression, pericardial effusion, pleural effusion. During the same period patient was treated with KETOCONAZOLE (200 Mg Po Bid X1, Qd X 3) (View Ketoconazole Review and Ketoconazole Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), TYLENOL W/ CODEINE NO. 3 (View Tylenol W/ Codeine No. 3 Review and Tylenol W/ Codeine No. 3 Label ), COLACE (View Colace Review and Colace Label ), TESSALON (View Tessalon Review and Tessalon Label ), THORAZINE (View Thorazine Review and Thorazine Label ), SENNOKOT (View Sennokot Review and Sennokot Label ). Patient was hospitalized.

4677721-9 | Abdominal Pain, Blood Amylase Increased, Diarrhoea, Diverticulum, Gastritis, Lipase Increased, Nausea, Oesophageal Ulcer
on May 27, 2005 Male patient from , weighting 189.6 lb, was diagnosed with metastasis, nasal sinus cancer and was treated with Rapamycin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), blood amylase increased, diarrhoea, diverticulum, gastritis, lipase increased, nausea (What is nausea?), oesophageal ulcer. Rapamycin dosage: 1 Mg Po Q Week. During the same period patient was treated with KETOCONAZOLE (200 Mg Po Bid X1, Qdx3) (View Ketoconazole Review and Ketoconazole Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), IMITREX (View Imitrex Review and Imitrex Label ), KEPPRA (View Keppra Review and Keppra Label ), LACTULOSE (View Lactulose Review and Lactulose Label ). Patient was hospitalized.

4665794-9 | Convulsion, Gastric Ulcer, Gastrointestinal Haemorrhage, Loss Of Consciousness, Mass, Syncope, Thrombosis, Tonic Clonic Movements, Urinary Incontinence
on May 16, 2005 Male patient from , weighting 187.4 lb, was diagnosed with oesophageal cancer metastatic and was treated with Rapamycin (View Usage). After Rapamycin was administered, patient had the following side effects: convulsion, gastric ulcer, gastrointestinal haemorrhage, loss of consciousness, mass, syncope, thrombosis, tonic clonic movements, urinary incontinence (What is urinary incontinence?). Rapamycin dosage: 1 Mg Po Q Week. During the same period patient was treated with KETOCONAZOLE (200 Mg Po Bid X1, Qdx3) (View Ketoconazole Review and Ketoconazole Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), SENNOKOT (View Sennokot Review and Sennokot Label ), TYLENOL W/ CODEINE NO. 3 (View Tylenol W/ Codeine No. 3 Review and Tylenol W/ Codeine No. 3 Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), COLACE (View Colace Review and Colace Label ), TESSALON (View Tessalon Review and Tessalon Label ). Patient was hospitalized.

4578589-1 | Asthenia, Disease Progression, Fatigue, Hepatic Failure, Renal Failure
Patient was taking Rapamycin (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, disease progression, fatigue, hepatic failure, renal failure on Feb 07, 2005 from Additional patient health information: Female patient , weighting 118.6 lb, was diagnosed with pancreatic carcinoma and. Rapamycin dosage: 2mg Qd Oral.

4559185-9 | Asthenia, Fatigue, Fluid Retention, Mediastinal Mass, Oedema Peripheral, Renal Failure, Skin Discolouration, Thrombosis
Adverse event was reported on Jan 21, 2005 by a Female patient taking Rapamycin (View Usage) (Dosage: 2mg Qd Oral) was diagnosed with pancreatic carcinoma and. Location: , weighting 118.6 lb, Patient had the following side effects: asthenia, fatigue, fluid retention, mediastinal mass, oedema peripheral, renal failure, skin discolouration, thrombosis. Patient was hospitalized.

4558230-4 | Gastrointestinal Haemorrhage, Leukocytosis, Meningitis Meningococcal, Meningitis Pneumococcal, Streptococcal Infection
on Nov 02, 2004 Male patient from , 53 years of age, was diagnosed with renal transplant and was treated with Rapamycin (View Usage). After Rapamycin was administered, patient had the following side effects: gastrointestinal haemorrhage, leukocytosis, meningitis meningococcal, meningitis pneumococcal, streptococcal infection (What is streptococcal infection?). Rapamycin dosage: 1.3 Mg Daily. During the same period patient was treated with NEORAL (75 Mg / Day) (View Neoral Review and Neoral Label ). Patient was hospitalized.